News Corporate

PRESS RELEASE

March 15, 2023 - Barcelona, Spain

Cover 2023

Werfen completes acquisition of Immucor, Inc., expanding leadership in Specialized Diagnostics

  • Werfen announced in November 2022 that it reached an agreement to acquire Immucor, Inc. for approximately US$2 billion.

  • The transaction has received all necessary regulatory approvals.

  • The Transfusion and Transplant product lines complement Werfen’s existing Hemostasis, Acute Care and Autoimmunity business lines, expanding its portfolio of specialized diagnostics solutions for hospitals and clinical laboratories.

 

Barcelona, March 15, 2023 - Werfen has successfully completed the acquisition of Immucor, Inc., after obtaining all necessary regulatory and antitrust approvals.

Immucor is a privately held, US-based company, in the in vitro diagnostics (IVD) sector, with a solid global presence in the Transfusion and Transplant markets.

“During our more than 50-year history, we have demonstrated our strong commitment to expand our IVD business through organic growth, complemented with highly strategic acquisitions,” said Carlos Pascual, CEO of Werfen.

The price of the acquisition was approximately US$2 billion and financed by a combination of cash on hand and bank debt facilities syndicated by 19 national and international entities, led by BBVA, BNP Paribas, CaixaBank and HSBC. As part of its credit management, Werfen plans to refinance part of the debt in the capital markets, as well as quickly reduce the level of indebtedness. Following the announcement of the acquisition, Standard & Poor’s affirmed Werfen’s investment grade rating (BBB-) with a stable outlook.

With the integration of Immucor, Inc., Werfen expands its presence as a company of reference in the Specialized Diagnostics market, and grows its portfolio of diagnostic solutions for hospitals and clinical laboratories. In addition, revenues will exceed €2.2 billion, and the Company will have seven technology centers and employ more than 7,000 people worldwide; with a direct presence in more than 30 countries and in more than 100 territories through distributors.

 

About Werfen

Founded in 1966, Werfen is a worldwide developer, manufacturer and distributor of Specialized Diagnostic instruments, related reagents, automation workcells, and data management solutions for use primarily in hospitals and independent clinical laboratories. The Company's business lines include Hemostasis, Acute Care Diagnostics, Autoimmunity, and Original Equipment Manufacturing (OEM). Werfen operates directly in more than 30 countries and in more than 100 territories through distributors. For more information, visit werfen.com

 

About Immucor

Founded in 1982, Immucor is a global leader in Transfusion and Transplant diagnostics, facilitating patient-donor compatibility. The Company strives to create a world where anyone, anywhere in need of a transfusion or a transplant receives the right blood or transplant that is safe, accessible, and affordable. With the right match, a life can be transformed, together. To learn more, visit immucor.com.

Press Contact

Investor Relations

Tel. +34 93 401 03 14

ir@werfen.com

 

Legal notice

This document contains forward-looking statements about our business, financial data, and events related to the prospects of Werfen. These forecasts can be identified by the use of words such as “expectation”, “vision”, “anticipation”, “intention”, “plan”, “belief”, “search”, “estimate”, “future”, “project”, or words with a similar meaning. We may also make projections in other reports, presentations, and press releases. Furthermore, our sales representatives may occasionally make forward-looking statements. These projections are based on our current expectations and on certain hypotheses, many of which are beyond the corporation’s control and subject to a series of risks and uncertainties. In the event that any of these risks or uncertainties should materialize or the underlying expectations are not fulfilled, the results or performance of Werfen may differ substantially (either positively or negatively) from those explicitly or implicitly forecast. Werfen assumes no obligation to update or revise any forward-looking statements made previously.

Share Press Release:

LinkedIn twitter facebook
Contact Us

Contact us directly filling out the form below.

Tel +61 2 9098 0200

DATA PROTECTION POLICY:

In application of the Personal Data Protection regulations, we inform that your personal data will be incorporated and processed in a file under the responsibility of WERFEN for the purpose of maintaining the commercial relationship (order management and / or billing, sending product notices, managing business relationships, including conducting surveys, prospecting, statistical analysis and other activities related to the management of business visits), as well as to provide by any means (electronic or not), information about our products and / or services that may be of interest to you.
 
Responsible for the treatment: WERFEN, with address at 59-61 Dickson Avenue, Artarmon, NSW 2064
 
Responsible for the data processing: WERFEN, S.A., with address at Plaza Europa, 21-23 - 08908 L'Hospitalet de Llobregat (Barcelona). CIF: A08754111
 
Data Protection Officer: enquiries-au@wefen.com

Legal basis of the treatment: The treatment is necessary for the execution of a commercial contract of product and / or service; and your consent - with respect to commercial communications, supply of products and / or services, market research and improvement of our website.

Recipients or categories of recipients: Werfen companies and third parties to which WERFEN has entrusted the provision of services (hosting, training and communication services, organization of events). When legally or contractually required.
 
Term of conservation: While you are a user of our products and / or services and / or of our web page and whenever you have not opposed receiving commercial communications. Subsequently, the data will be maintained, duly blocked, for a period of 5 years.
 
Rights: You can exercise the rights of access, rectification or deletion, as well as request to limit your data processing, oppose it, request the portability of your data, or revoke the consent given by writing to enquiries-au@werfen.com​
 
Likewise, the data subject is entitled to lodge a complaint with the OAIC https://www.oaic.gov.au/privacy/privacy-complaints/
 
The information you are sending us via this form will be used for the sole purpose of responding to your request and, therefore, this may be transferred to other Werfen companies or subsidiaries in other countries.
 
By clicking “I accept”, you agree that your data will be governed by our Data Protection Policy